SYDNEY,March 10,2025-- Appian (NASDAQ: APPN) today announced the latest version of the Appian Platform,which delivers improved scalability,speed,and performance for enterprise applications. Appian 25
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar
BEIJING,March 9,2025-- A report from People\'s Daily: China has unveiled a 2025 action plan to stabilize foreign investment,outlining 20 policy initiatives across four strategic priorities: phased exp
SYDNEY,March 10,2025-- HKA,a leading global consultancy in risk mitigation and dispute resolution,is excited to announce that Jacqueline Woods has joined its rapidly expanding Forensic Accounting and
LONDON,March 10,2025-- UK-based public health agency,Knowledge•Action•Change(K•A•C),is launching a free online course called Understanding Tobacco Harm Reductionin a bid to reduce the disease and
Yunnan: Province sets year\'s target at 6 million sojourners BEIJING,March 10,2025-- A report fromChinadaily.com.cn
